malondialdehyde has been researched along with c-peptide in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Serov, VN; Sterliagova, LI | 1 |
| Caffau, C; Cernigoi, AM; Dapas, F; De Monte, A; Velussi, M; Zilli, M | 1 |
| Beccarello, A; Crepaldi, G; De Monte, A; Donadon, V; Lirussi, F; Velussi, M; Zanette, G | 1 |
| Laurini, RN; Olofsson, P; Saldeen, P | 1 |
| Abdel-Hamid, M; El-Meligi, AA; Elhendy, A; Ibrahim, HA | 1 |
| Kocić, G; Kocić, R; Pavlović, D; Pesić, M | 1 |
| Gao, C; Guo, LY; Li, DP; Wei, Y; Zhang, J; Zhang, L; Zhang, Y; Zhou, JJ | 1 |
| Cao, Z; Fan, D; Li, D; Li, M; Mao, Y; Peng, C; Xie, X | 1 |
| Chen, WX; Sui, DJ; Yang, M; Yu, DW | 1 |
| Abdelkader, NF; Badawi, MA; Eitah, HE; Gamal El Din, AA; Kenawy, SA; Maklad, YA | 1 |
| Abdelkader, NF; Badawi, MA; Eitah, HE; Gamaleldin, AA; Kenawy, SA; Maklad, YA | 1 |
2 trial(s) available for malondialdehyde and c-peptide
| Article | Year |
|---|---|
Long-term (12 months) treatment with an anti-oxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients.
Topics: Aged; Antioxidants; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glycosuria; Humans; Hyperinsulinism; Insulin; Liver Cirrhosis, Alcoholic; Male; Malondialdehyde; Middle Aged; Silymarin; Time Factors | 1997 |
Silybin-beta-cyclodextrin in the treatment of patients with diabetes mellitus and alcoholic liver disease. Efficacy study of a new preparation of an anti-oxidant agent.
Topics: Antioxidants; beta-Cyclodextrins; Blood Glucose; C-Peptide; Cholesterol, HDL; Cyclodextrins; Diabetes Mellitus, Type 2; Double-Blind Method; Female; gamma-Glutamyltransferase; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Liver Diseases, Alcoholic; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Placebos; Silybin; Silymarin; Triglycerides | 2002 |
9 other study(ies) available for malondialdehyde and c-peptide
| Article | Year |
|---|---|
[Informative value of various biochemical parameters of homeostasis in the formation of endometrial cancer risk groups].
Topics: C-Peptide; Endometrial Hyperplasia; Female; Humans; Lipid Peroxidation; Malondialdehyde; Molecular Weight; Risk Factors; Toxins, Biological; Uterine Neoplasms | 1991 |
Signs of platelet activation, but not lipid peroxidation, in fetal blood associated with functional and structural umbilicoplacental lesions in pregnancies complicated by impaired glucose metabolism.
Topics: 6-Ketoprostaglandin F1 alpha; C-Peptide; Embryonic and Fetal Development; Epoprostenol; Female; Fetal Blood; Glucose Intolerance; Glycated Hemoglobin; Humans; Lipid Peroxidation; Malondialdehyde; Placenta; Placenta Diseases; Platelet Activation; Pregnancy; Pregnancy in Diabetics; Thromboxane A2; Thromboxane B2; Umbilical Arteries; Umbilical Veins | 2002 |
Relations between von Willebrand factor, markers of oxidative stress and microalbuminuria in patients with type 2 diabetes mellitus.
Topics: Albuminuria; Ascorbic Acid; C-Peptide; Diabetes Mellitus, Type 2; Female; Glutathione; Humans; Male; Malondialdehyde; Oxidative Stress; Platelet Adhesiveness; von Willebrand Factor | 2004 |
Susceptibility to oxidative stress, insulin resistance, and insulin secretory response in the development of diabetes from obesity.
Topics: Adult; Antioxidants; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucagon; Humans; Insulin; Insulin Resistance; Insulin Secretion; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Obesity; Oxidative Stress | 2007 |
Chronic intermittent hypobaric hypoxia prevents cardiac dysfunction through enhancing antioxidation in fructose-fed rats.
Topics: Animal Feed; Animals; Antioxidants; Blood Glucose; Blood Pressure; C-Peptide; Cholesterol; Fructose; Heart; Hypoxia; Insulin; Male; Malondialdehyde; Myocardium; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Superoxide Dismutase; Triglycerides; Ventricular Function, Left | 2013 |
Antidiabetic effect of flavonoids from Malus toringoides (Rehd.) Hughes leaves in diabetic mice and rats.
Topics: Animals; Behavior, Animal; Blood Glucose; Body Weight; C-Peptide; Diabetes Mellitus, Experimental; Female; Flavonoids; Glycated Hemoglobin; Hypoglycemic Agents; Insulin; Liver; Male; Malondialdehyde; Malus; Mice; Phytotherapy; Plant Leaves; Rats, Sprague-Dawley; Superoxide Dismutase | 2014 |
[Study on hypoglycemic effect and mechanism of total flavonoids of Propolis in STZ diabetic rats].
Topics: Animals; C-Peptide; Diabetes Mellitus, Experimental; Diet, High-Fat; Fatty Acids, Nonesterified; Flavonoids; Glucose; Glycated Hemoglobin; Hypoglycemic Agents; Liver; Malondialdehyde; Propolis; Rats; Streptozocin; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2014 |
Modulating impacts of quercetin/sitagliptin combination on streptozotocin-induced diabetes mellitus in rats.
Topics: Animals; Antioxidants; Biomarkers; Blood Glucose; C-Peptide; Diabetes Mellitus, Experimental; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glutathione; Insulin-Secreting Cells; Male; Malondialdehyde; NF-kappa B; Oxidative Stress; Quercetin; Rats, Wistar; Sitagliptin Phosphate; Streptozocin; Superoxide Dismutase | 2019 |
New combination therapy of gliclazide and quercetin for protection against STZ-induced diabetic rats.
Topics: Animals; Blood Glucose; C-Peptide; Cholesterol; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Gliclazide; Glutathione; Hypoglycemic Agents; Inflammation; Insulin; Islets of Langerhans; Male; Malondialdehyde; NF-kappa B; Oxidative Stress; Pancreas; Quercetin; Rats; Rats, Wistar; Streptozocin; Superoxide Dismutase; Triglycerides; Tumor Necrosis Factor-alpha | 2020 |